May 9, 2018 / 11:36 AM / 2 months ago

BRIEF-Jounce Therapeutics Q1 Shr Loss $0.40

May 9 (Reuters) - Jounce Therapeutics Inc:

* JOUNCE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* JOUNCE THERAPEUTICS Q1 COLLABORATION REVENUE $11.2 MILLION

* Q1 LOSS PER SHARE $0.40

* Q1 EARNINGS PER SHARE VIEW $-0.31 — THOMSON REUTERS I/B/E/S

* Q1 REVENUE VIEW $15.1 MILLION — THOMSON REUTERS I/B/E/S

* CONTINUES TO EXPECT CASH BURN ON OPERATING EXPENSES, CAPEX FOR 2018 TO BE APPROXIMATELY $80.0 MILLION TO $100.0 MILLION

* EXPECTS TO RECORD APPROXIMATELY $50.0 MILLION TO $60.0 MILLION IN COLLABORATION REVENUE IN 2018

* EXPECTS EXISTING CASH, CASH EQUIVALENTS, INVESTMENTS TO BE SUFFICIENT TO FUND REQUIREMENTS FOR AT LEAST NEXT 24 MONTHS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below